STOCK TITAN

MariMed Awarded Dispensary License in Ohio

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

MariMed Inc. (OTCQX: MRMD) has been awarded a provisional dispensary license by the Ohio Board of Pharmacy, enabling the development of a medical dispensary in Tiffin, Ohio. This license was secured through Ohio's lottery process, and the company must complete the buildout and pass inspection by February 2023. MariMed plans to expand its operations in Ohio, aiming to maximize its cannabis licenses under state regulations. With over $350 million in medical cannabis sales in 2021 and 260,000 registered patients, Ohio presents significant growth opportunities for MariMed.

Positive
  • Awarded a provisional dispensary license in Ohio, expanding operational footprint.
  • Plans to pursue additional cannabis licenses to enhance market presence.
  • Ohio's medical cannabis market had over $350 million in sales in 2021.
Negative
  • Must complete dispensary buildout and pass inspection by February 2023, posing a time constraint.

NORWOOD, Mass., May 18, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, announced today it had been awarded a provisional dispensary license (“PDL”) by the Ohio Board of Pharmacy.

MariMed won this license in the Ohio lottery process. The license allows the Company to develop a medical dispensary in Tiffin, Ohio, located south of Toledo and home to the University of Bucharest and Tiffin University.   Under the Ohio regulations, MariMed must complete the buildout and pass final inspection by February of 2023.

“We are delighted to enter the medical cannabis program in Ohio,” said Bob Fireman, Chief Executive Officer of MariMed. “We intend to seek additional opportunities to expand our cannabis operations in Ohio including the distribution of our award-winning branded products.”

Ohio cannabis regulations allow for a single company to own cultivation, production, and up to five retail dispensaries. In keeping with its strategic growth plan, MariMed will over time pursue other cannabis licenses to increase its operational footprint to the maximum allowable by Ohio regulations.

According to the Ohio Department of Commerce, 2021 medical cannabis sales were just over $350 million with 58 dispensaries in a state with a population of nearly 12 million. Ohio’s legal medical cannabis program currently has more than 260,000 registered patients. With robust adult use cannabis programs in neighboring Midwest states of Michigan and Illinois, discussions for an adult use program continue in the Ohio legislature.

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

For More Information, Contact:

Investor Relations:
Steve West, Vice President, Investor Relations
Email: ir@marimedinc.com

Media Contact:
Trailblaze PR
Email: marimed@trailblaze.co

Company Contact:
Howard Schacter, Chief Communications Officer
Email: hschacter@marimedinc.com


FAQ

What is the latest announcement from MariMed regarding the Ohio dispensary?

MariMed has been awarded a provisional dispensary license by the Ohio Board of Pharmacy to develop a medical dispensary in Tiffin, Ohio.

When must MariMed complete the buildout for the Ohio dispensary?

MariMed must complete the buildout and pass inspection by February 2023.

How does MariMed plan to expand in Ohio after receiving the license?

MariMed intends to pursue additional opportunities and cannabis licenses to expand its operations in Ohio.

What were the medical cannabis sales figures in Ohio in 2021?

Ohio's medical cannabis sales exceeded $350 million in 2021.

What is the significance of the Ohio provisional dispensary license for MRMD?

The provisional dispensary license allows MRMD to enter a growing medical cannabis market and expand its operational capabilities.

MARIMED INC

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

55.29M
280.32M
14.03%
0.3%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Norwood